Menu
About / Company Overview
Founded in Edinburgh in 2014 and headquartered in Boston, Current Health gives health systems, community practices, and pharma and biotech companies the safety, operating, and evidence infrastructure to deliver advanced therapies and acute care beyond the hospital.
Our mission
To be the industry's premier safety, operating, and evidence infrastructure for making transformative advanced treatments accessible and sustainably affordable at scale.
Advanced therapies like CAR-T, bispecifics, and cell and gene therapies are transforming medicine, offering cures where none existed before. But these high-cost treatments often require extended inpatient stays and are only available at select academic medical centers. We're building the infrastructure to help make these emerging therapies more accessible to the patients who need them. By enabling safe ambulatory and home-based delivery, we expand access, reduce costs, and improve the patient experience, all while preserving the highest standards of safety and care quality.
Our vision
Our story
2014
Current Health founded in Edinburgh with a mission to deliver a safe, sustainable way to provide acute care at home. Built FDA-cleared technology and clinical infrastructure from the ground up.
2019
Expanded to the United States, landing partnerships with leading health systems and global pharma companies. Established research-based credibility with peer-reviewed publications.
2021
Became the largest provider of hospital at home technology and services in the United States.
2023
Partnered with Sarah Cannon to launch the largest multisite outpatient CAR-T program.
2025
Market leader in outpatient and community CAR-T, bispecific, and advanced therapy enablement. Landed strategic partnerships with global pharma companies.
What we stand for
We build infrastructure that reduces burden, not adds to it.
Recover at home with family, not in a hospital bed.
Bring life-saving therapies closer to where patients live.
Sustainable economics for everyone.
Regulatory and compliance
Our platform is a regulated medical device, and our clinical team handles protected health information every day, for health systems, practices, and trial sponsors.
The Current Health System is an FDA-cleared Class II physiological monitoring system, with five 510(k) clearances since 2019, most recently in 2023.
CE marked as a Class IIa medical device for use across EU member states.
Trial data delivered to your EDC with 21 CFR Part 11 audit trails.
Protected health information handled in line with US healthcare data privacy and security requirements.
Quality management system certification for medical device design and manufacturing.
Third-party validated security controls for data protection and operational integrity.
Where we work
US headquarters
Commercial, clinical operations, and customer success
Engineering and product
Platform development, device engineering, and data science
Leadership
CEO and Co-founder
Chief Medical Officer
Chief Operating Officer
Chief Financial Officer
Chief Strategy Officer
SVP of Commercial Growth
VP of Product
VP of R&D
VP of Engineering
VP of Marketing
We'll help you find the right starting point, whether you're shortening length of stay or scaling full outpatient delivery.